Evidence map›Paper›PMID 40530385›Full record

ReviewIJTLD open2025

Progress and challenges to TB elimination in New South Wales, Australia.

E J Donnan, J Pett, E Ulbricht, P D Massey, V Sintchenko, B J Marais

Abstract readReview
In one paragraph

Review in IJTLD open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Spatio-temporal patterns of tuberculosis revealed by routineThe Lancet regional health. Western Pacific · 2026
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

E J DonnanHealth Protection New South Wales, Health System Support Group, St Leonards, NSW, Australia.
J PettHealth Protection New South Wales, Health System Support Group, St Leonards, NSW, Australia.
E UlbrichtHealth Protection New South Wales, Health System Support Group, St Leonards, NSW, Australia.
P D MasseyHunter New England Population Health, Hunter New England Local Health District, Newcastle, NSW, Australia.
V SintchenkoSydney Infectious Diseases Institute (Sydney ID), The University of Sydney, Sydney, NSW, Australia.
B J MaraisSydney Infectious Diseases Institute (Sydney ID), The University of Sydney, Sydney, NSW, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In Australia, TB care and control is delivered by states and territories, with a National TB Advisory Committee to advise on national surveillance and strategy. For more than 30 years, New South Wales (NSW), Australia, has maintained TB incidence rates of <10/100,000 population, but progress toward TB elimination and 'zero local TB transmission' remains challenging. Reductions in the TB notification rate have plateaued in recent decades, mainly due to increased migration from high incidence countries. There is limited awareness of TB among the public, and a general perception of low risk, at least for Australian-born people and locally trained healthcare professionals. As in other low TB incidence settings, migrants and hard-to-reach populations are overrepresented in TB notifications. Progress in reducing TB among Australia's Aboriginal and Torres Strait Islander people has been slow, hindered by embedded disadvantage, limited healthcare access and historical mistrust. Community engagement and patient advocacy for TB is minimal. Despite excellent progress over many decades, TB elimination remains out of reach in NSW due to ongoing migration from high-incidence settings and the reality of competing health priorities. Here, we critically assess progress towards TB elimination targets and identify opportunities to further improve TB control.

Indexed as

active case findingepidemiologymigrationprevention/control programmescreeningTBItransmissiontuberculosis

Identifiers

PMID40530385
PMCPMC12168733

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.